Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Cardiac Electrophysiology Clinics|November 28, 2017
Heart Failure and Sudden Cardiac DeathBasil Saour, Bryan Smith, Clyde W YancyCurrent Treatment Options in Cardiovascular Medicine|September 6, 2019
Leadless Pacemakers: Recent and Future DevelopmentsAnne Kroman, Basil Saour, Jordan M PrutkinClinical Case Reports|July 31, 2019
Management of S-ICD lead in a patient requiring sternotomyBasil Saour, Rachel Kaplan, Austin Ward, et al.Pacing and Clinical Electrophysiology : PACE|June 25, 2019
Increased risk of hematoma with uninterrupted warfarin in patients undergoing implantation of subcutaneous implantable cardioverter defibrillatorChristopher Evenson, Basil Saour, Muhammad R Afzal, et al.Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|March 12, 2018
Dialytic interval and the timing of electrocardiographic screening for subcutaneous cardioverter-defibrillator placement in chronic hemodialysis patientsCindy You, Shishir Sharma, Aakash Bavishi, et al.Nutrition and Cancer|June 25, 2010
Antiproliferative mechanisms of the flavonoids 2,2'-dihydroxychalcone and fisetin in human prostate cancer cellsAhmed Q Haddad, Neil Fleshner, Colleen Nelson, et al.Heart Rhythm O2|August 25, 2020
QT interval and arrhythmic safety of hydroxychloroquine monotherapy in coronavirus disease 2019Arun R Sridhar, Neal A Chatterjee, Basil Saour, et al.Cardiology and Therapy|October 15, 2020
Safety and Effectiveness of Hydroxychloroquine and Azithromycin Combination Therapy for Treatment of Hospitalized Patients with COVID-19: A Propensity-Matched StudyHenry D Huang, Hani Jneid, Mariam Aziz, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 26, 2015
Subcutaneous implantable cardioverter defibrillator for dialysis patients: a strategy to reduce central vein stenoses and infectionsRajiv K Dhamija, Henry Tan, Edward Philbin, et al.The American Journal of Cardiology|August 4, 2018
Outcomes With Novel Oral Anticoagulants in Obese Patients who Underwent Electrical Cardioversion for Atrial TachyarrhythmiasRachel M Kaplan, Celso L Diaz, Theresa Strzelczyk, et al.Pageof 2